Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Academy Sports and Outdoors | ASO | Nov 15, 2024 | 47.80 | -3.02 |
Acadia Healthcare | ACHC | Nov 15, 2024 | 37.82 | -3.91 |
Acadia Pharmaceuticals | ACAD | Nov 15, 2024 | 16.77 | -1.47 |
Acadia Realty Trust | AKR | Nov 15, 2024 | 24.60 | +0.49 |
Acasti Pharma, Inc. | ACST | Nov 15, 2024 | 3.37 | 0.00 |
Accel Entertainment | ACEL | Nov 15, 2024 | 11.55 | -1.87 |
Accelerate Diagnostics | AXDX | Nov 15, 2024 | 1.85 | -1.07 |
Accenture A | ACN | Nov 15, 2024 | 353.57 | -2.35 |
Acco Brands | ACCO | Nov 15, 2024 | 5.82 | -3.48 |
Accolade | ACCD | Nov 15, 2024 | 3.47 | -3.61 |
Accuray | ARAY | Nov 15, 2024 | 1.70 | -2.30 |
Acelyrin | SLRN | Nov 15, 2024 | 4.69 | -9.11 |
Achieve Life Sciences | ACHV | Nov 15, 2024 | 4.25 | -3.19 |
Achilles Therapeutics ADR | ACHL | Nov 15, 2024 | 1.05 | -1.87 |
ACI Worldwide | ACIW | Nov 15, 2024 | 54.29 | -1.29 |
Aclarion | ACON | Nov 15, 2024 | 0.16 | -3.88 |
Aclaris Therapeutics | ACRS | Nov 15, 2024 | 2.05 | -5.96 |
ACM Research A | ACMR | Nov 15, 2024 | 18.33 | -2.14 |
Acme United | ACU | Nov 15, 2024 | 41.97 | -1.27 |
ACNB | ACNB | Nov 15, 2024 | 47.45 | -0.11 |
ACRES Commercial Realty | ACR | Nov 15, 2024 | 16.74 | +3.72 |
ACRES Commercial Realty C Pref | ACR-C | Nov 15, 2024 | 25.05 | +0.24 |
ACRES Commercial Realty D Pref | ACR-D | Nov 15, 2024 | 23.15 | +0.35 |
Acrivon Therapeutics | ACRV | Nov 15, 2024 | 6.96 | -12.12 |
Actelis Networks | ASNS | Nov 15, 2024 | 1.27 | -4.51 |
Actinium Pharmaceuticals | ATNM | Nov 15, 2024 | 1.50 | -9.09 |
Active Bear ETF | HDGE | Nov 15, 2024 | 17.71 | +1.50 |
Active U.S. Real Estate Powershares | PSR | Nov 15, 2024 | 95.21 | +0.40 |
Actuate Therapeutics | ACTU | Nov 15, 2024 | 8.68 | +1.52 |
Acuity Brands | AYI | Nov 15, 2024 | 325.87 | -1.14 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.